SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HHCA. Home Health Corp of America

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Miller who wrote (6)11/23/1997 10:14:00 PM
From: Joe Dancy  Read Replies (1) of 25
 
Help me here. I just got done using Zack's screens and HHCA was one of the few "survivors". WIth a five year estimated earnings growth rate of 23%, a current PE of 11 and PE on next years earnings of 9, all four analysts who cover rate it as a buy or strong buy, revenues are growing, price to book of 1.4, price to sales of 0.4 - a number of acquisitions that should make the company stronger according to the analysts - good articles in the press that I found - a small cap ($75 million) so has some real potential as an overlooked stock that the funds can't touch because of their size.

What's the problem? Are they involved in any medicaid/medicare reimbursement problems? Is there any pending legislation/regulations to cut reimbursements?

From what I've read it looks interesting - calling the company Monday for 10K and annual report and any other stuff they can send.

Thanks for any info you can provide. I agree I like this sector - will grow greatly over the next decade or more. Recently bought into BIOI - a supplier of biotech research kits/materials.

Best - Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext